Implantable Cardioverter Defibrillator Management: an Update

References

• Mendis SPP , NorrvingB . Global atlas on cardiovascular disease prevention and control . WHO, Geneva, Switzerland ( 2011 ). www.world-heart-federation.org .
   Google Scholar
• Priori SG , Blomström-LundqvistC, MazzantiAet al. Authors/Task Force Members; Document Reviewers. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC) . Eur. Heart J.36 ( 41 ), 2793 – 2867 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Mozaffarian D , BenjaminEJ, GoASet al. Heart disease and stroke statistics-2016 update: a report from the American Heart Association . Circulation133 ( 4 ), e38 – e360 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Cobb LA , BaumRS, AlvarezHIII, SchafferWA . Resuscitation from out-of-hospital ventricular fibrillation: 4 years follow-up . Circulation52 ( Suppl. 6 ), III223 – III235 ( 1975 ).
   PubMed Web of Science ®Google Scholar
• Berdowski J , ten HaafM, TijssenJG, ChapmanFW, KosterRW . Time in recurrent ventricular fibrillation and survival after out-of-hospital cardiac arrest . Circulation122 ( 11 ), 1101 – 1108 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Mirowski M , ReidPR, MowerMMet al. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings . N. Engl. J. Med.303 ( 6 ), 322 – 324 ( 1980 ).
   PubMed Web of Science ®Google Scholar
• Trappe HJ . The “modern” implantable cardioverter-defibrillator: comparing it to those of the late 1980s . Am. J. Cardiol.78 ( 5A ), 3 – 8 ( 1996 ).
   PubMed Web of Science ®Google Scholar
• Hohnloser SH , KuckKH, DorianPet al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction . N. Engl. J. Med.351 ( 24 ), 2481 – 2488 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Steinbeck G , AndresenD, SeidlKet al. Defibrillator implantation early after myocardial infarction . N. Engl. J. Med.361 ( 15 ), 1427 – 1436 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Elliott PM , AnastasakisA, BorgerMAet al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC) . Eur. Heart J.35 ( 39 ), 2733 – 2779 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Holley LK . Development of device therapy for ventricular arrhythmias . Heart Lung Circ.16 ( 3 ), 162 – 169 ( 2007 ).
   PubMedGoogle Scholar
• Sweeney MO . Antitachycardia pacing for ventricular tachycardia using implantable cardioverter defibrillators . Pacing Clin. Electrophysiol.27 ( 9 ), 1292 – 1305 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Wietholt D , BlockM, IsbruchFet al. Clinical experience with antitachycardia pacing and improved detection algorithms in a new implantable cardioverter-defibrillator . J. Am. Coll. Cardiol.21 ( 4 ), 885 – 894 ( 1993 ).
   PubMed Web of Science ®Google Scholar
• Swerdlow CD , FriedmanPA . Advanced ICD troubleshooting: part I . Pacing Clin. Electrophysiol.28 ( 12 ), 1322 – 1346 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Poole JE , JohnsonGW, HellkampASet al. Prognostic importance of defibrillator shocks in patients with heart failure . N. Engl. J. Med.359 ( 10 ), 1009 – 1017 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Ellenbogen KA , KayGN, LauC, WilkoffBL . Clinical Cardiac Pacing, Defibrillation And Resynchronization Therapy (3rd Edition) . Saunders, Elsevier Inc., Philadelphia, PA, USA ( 2007 ).
   Google Scholar
• Migliore F , CurnisA, BertagliaE . Axillary vein technique for pacemaker and implantable defibrillator leads implantation: a safe and alternative approach?J. Cardiovasc. Med. (Hagerstown)17 ( 4 ), 309 – 313 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Kirkfeldt RE , JohansenJB, NohrEA, MollerM, ArnsboP, NielsenJC . Pneumothorax in cardiac pacing: a population-based cohort study of 28,860 Danish patients . Europace14 ( 8 ), 1132 – 1138 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Blatt JA , PooleJE, JohnsonGWet al. No benefit from defibrillation threshold testing in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial) . J. Am. Coll. Cardiol.52 ( 7 ), 551 – 556 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Brignole M , OcchettaE, BongiorniMGet al. Clinical evaluation of defibrillation testing in an unselected population of 2,120 consecutive patients undergoing first implantable cardioverter-defibrillator implant . J. Am. Coll. Cardiol.60 ( 11 ), 981 – 987 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Stavrakis S , PatelNH, ReynoldsDW . Defibrillation threshold testing does not predict clinical outcomes during long-term follow-up: a meta-analysis . Pacing Clin. Electrophysiol.36 ( 11 ), 1402 – 1408 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Birnie D , TungS, SimpsonCet al. Complications associated with defibrillation threshold testing: the Canadian experience . Heart Rhythm5 ( 3 ), 387 – 390 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• van Rees JB , BorleffsCJ, de BieMKet al. Inappropriate implantable cardioverter-defibrillator shocks: incidence, predictors, and impact on mortality . J. Am. Coll. Cardiol.57 ( 5 ), 556 – 562 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Moss AJ , SchugerC, BeckCAet al. Reduction in inappropriate therapy and mortality through ICD programming . N. Engl. J. Med.367 ( 24 ), 2275 – 2283 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Tan VH , WiltonSB, KuriachanV, SumnerGL, ExnerDV . Impact of programming strategies aimed at reducing nonessential implantable cardioverter defibrillator therapies on mortality: a systematic review and meta-analysis . Circ. Arrhythm. Electrophysiol.7 ( 1 ), 164 – 170 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Schaer B , KühneM, ReichlinT, OsswaldS, SticherlingC . Incidence of and predictors for appropriate implantable cardioverter-defibrillator therapy in patients with a secondary preventive implantable cardioverter-defibrillator indication . Europace18 ( 2 ), 227 – 231 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Reynolds MR , CohenDJ, KugelmassADet al. The frequency and incremental cost of major complications among medicare beneficiaries receiving implantable cardioverter-defibrillators . J. Am. Coll. Cardiol.47 ( 12 ), 2493 – 2497 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Ezzat VA , LeeV, AhsanSet al. A systematic review of ICD complications in randomised controlled trials versus registries: is our ‘real-world’ data an underestimation? Open Heart 2 ( 1 ), e000198 ( 2015 ).
   PubMedGoogle Scholar
• Kirkfeldt RE , JohansenJB, NohrEA, J⊘rgensenOD, NielsenJC . Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark . Eur. Heart J.35 ( 18 ), 1186 – 1194 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Lee DS , KrahnAD, HealeyJSet al. Evaluation of early complications related to De novo cardioverter defibrillator implantation insights from the Ontario ICD database . J. Am. Coll. Cardiol.55 ( 8 ), 774 – 782 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Pang BJ , BaroldSS, MondHG . Injury to the coronary arteries and related structures by implantation of cardiac implantable electronic devices . Europace17 ( 4 ), 524 – 529 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Kutinsky IB , JarandillaR, JewettM, HainesDE . Risk of hematoma complications after device implant in the clopidogrel era . Circ. Arrhythm. Electrophysiol.3 ( 4 ), 312 – 318 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• van Rees JB , de BieMK, ThijssenJ, BorleffsCJ, SchalijMJ, van ErvenL . Implantation-related complications of implantable cardioverter-defibrillators and cardiac resynchronization therapy devices: a systematic review of randomized clinical trials . J. Am. Coll. Cardiol.58 ( 10 ), 995 – 1000 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Buiten MS , De BieMK, Van Der HeijdenACet al. Chronic kidney disease and implantable cardioverter defibrillator related complications: 16 years of experience . J. Cardiovasc. Electrophysiol.25 ( 9 ), 998 – 1004 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Birnie DH , HealeyJS, WellsGAet al. Pacemaker or defibrillator surgery without interruption of anticoagulation . N. Engl. J. Med.368 ( 22 ), 2084 – 2093 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Doughty DB . Preventing and managing surgical wound dehiscence . Adv. Skin Wound Care18 ( 6 ), 319 – 322 ( 2005 ).
   PubMedGoogle Scholar
• Korantzopoulos P , SiderisS, DilaverisP, GatzoulisK, GoudevenosJA . Infection control in implantation of cardiac implantable electronic devices: current evidence, controversial points, and unresolved issues . Europace18 ( 4 ), 473 – 478 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Da Costa A , KirkorianG, CucheratMet al. Antibiotic prophylaxis for permanent pacemaker implantation: a meta-analysis . Circulation97 ( 18 ), 1796 – 1801 ( 1998 ).
   PubMed Web of Science ®Google Scholar
• Bloom HL , ConstantinL, DanDet al. Implantation success and infection in cardiovascular implantable electronic device procedures utilizing an antibacterial envelope . Pacing Clin. Electrophysiol.34 ( 2 ), 133 – 142 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Polyzos KA , KonstanteliasAA, FalagasME . Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis . Europace17 ( 5 ), 767 – 777 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Magyar-Russell G , ThombsBD, CaiJXet al. The prevalence of anxiety and depression in adults with implantable cardioverter defibrillators: a systematic review . J. Psychosom. Res.71 ( 4 ), 223 – 231 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Braunschweig F , BorianiG, BauerAet al. Management of patients receiving implantable cardiac defibrillator shocks: recommendations for acute and long-term patient management . Europace12 ( 12 ), 1673 – 1690 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Starrenburg A , PedersenS, van den BroekK, KraaierK, ScholtenM, Van der PalenJ . Gender differences in psychological distress and quality of life in patients with an ICD 1 year postimplant . Pacing Clin. Electrophysiol.37 ( 7 ), 843 – 852 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• van der Heijden AC , BorleffsCJ, BuitenMSet al. Clinical course of patients with implantable cardioverter-defibrillators: extended experience on clinical outcome, device replacements, and device-related complications . Heart Rhythm12 ( 6 ), 1169 – 1176 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Sabbag A , SuleimanM, Laish-FarkashAet al. Contemporary rates of appropriate shock therapy in patients who receive implantable device therapy in a real-world setting: from the Israeli ICD registry . Heart Rhythm12 ( 12 ), 2426 – 2433 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Singh SN , PooleJ, AndersonJet al. Role of amiodarone or implantable cardioverter/defibrillator in patients with atrial fibrillation and heart failure . Am. Heart J.152 ( 5 ), 974.e7 – 974.e11 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Sears SF , TodaroJF, UrizarGet al. Assessing the psychosocial impact of the ICD: a national survey of implantable cardioverter defibrillator health care provides . Pacing Clin. Electrophysiol.23 ( 6 ), 939 – 945 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Rosenqvist M , BeyerT, BlockM, den DulkK, MintenJ, LindemansF . Adverse events in transvenous implantable cardioverter-defibrillators: a prospective multicenter study. European 7219 Jewel ICD investigators . Circulation98 ( 7 ), 663 – 670 ( 1998 ).
   PubMed Web of Science ®Google Scholar
• Daubert JP , ZarebaW, CannomDSet al. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact . J. Am. Coll. Cardiol.51 ( 14 ), 1357 – 1365 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Shah H , MezuU, PatelDet al. Mechanisms of inappropriate defibrillator therapy in a modern cohort of remotely monitored patients . Pacing Clin. Electrophysiol.36 ( 5 ), 547 – 552 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Hohnloser SH , Al-KhalidiHR, PrattCMet al. Electrical storm in patients with an implantable defibrillator: incidence, features, and preventive therapy: insights from a randomized trial . Eur. Heart J.27 ( 24 ), 3027 – 3032 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Sesselberg HW , MossAJ, McNittSet al. Ventricular arrhythmia storms in postinfarction patients with implantable defibrillators for primary prevention indications: a MADIT-II substudy . Heart Rhythm4 ( 11 ), 1395 – 1402 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Epstein AE , DimarcoJP, EllenbogenKAet al. ACC/AHA/HRS 2008 Guidelines for devices-based therapy of cardiac rhythm abnormalites . Heart Rhythm5 ( 6 ), e1 – e62 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Cronin EM , VarmaN . Remote monitoring of cardiovascular implanted electronic devices: a paradigm shift for the 21th century . Expert Rev. Med. Devices9 ( 4 ), 367 – 376 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• S⊘rensen JT , ClommensenP, SejerstenM . Telecardiology: past, present and future . Rev. Esp. Cardiol.66 ( 3 ), 212 – 218 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Varma N , EpsteinAE, IrimpenA, SchweikertR, LoveC . TRUST Investigators . Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up: the Lumos-T Safely Reduces Routine Office Device Follow-up (TRUST) trial . Circulation122 ( 4 ), 325 – 332 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Varma N , MichalskiJ, EpsteinAE, SchweikertR . Automatic remote monitoring of implantable cardioverter-defibrillator lead and generator performance: the Lumos-T Safely RedUceS RouTine Office Device Follow-Up (TRUST) trial . Circ. Arrhythm. Electrophysiol.3 ( 5 ), 428 – 436 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Martin DT , BersohnMM, WaldoALet al. Randomized trial of atrial arrhythmia monitoring to guide anticoagulation in patients with implanted defibrillator and cardiac resynchronization devices . Eur. Heart J.36 ( 26 ), 1660 – 1668 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Vollmann D , NägeleH, SchauertePet al. Clinical utility of intrathoracic impedance monitoring to alert patients with an implanted device of deteriorating chronic heart failure . Eur. Heart J.28 ( 15 ), 1835 – 1840 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Boriani G , Da CostaA, RicciRPet al. The MOnitoring Resynchronization dEvices and CARdiac patiEnts (MORE-CARE) randomized controlled trial: Phase 1 results on dynamics of early intervention with remote monitoring . J. Med. Internet. Res.15 ( 8 ), e167 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Oliveira M , CunhaPS, Da SilvaN . Remote monitoring for follow-up of patients with implantable cardiac device . Rev. Port. Cardiol.32 ( 3 ), 185 – 190 ( 2013 ).
   PubMedGoogle Scholar
• Parekh PJ , BuerleinRC, ShamsR, HerreJ, JohnsonDA . An update on the management of implanted cardiac devices during electrosurgical procedures . Gastrointest. Endosc.78 ( 6 ), 836 – 841 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Crossley GH , PooleJE, RoznerMAet al. The Heart Rhythm Society (HRS)/American Society of Anesthesiologists (ASA) Expert Consensus Statement on the perioperative management of patients with implantable defibrillators, pacemakers and arrhythmia monitors: facilities and patient management this document was developed as a joint project with the American Society of Anesthesiologists (ASA), and in collaboration with the American Heart Association (AHA), and the Society of Thoracic Surgeons (STS) . Heart Rhythm8 ( 7 ), 1114 – 1154 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Nordbeck P , ErtlG, RitterO . Magnetic resonance imaging safety in pacemaker and implantable cardioverter defibrillator patients: how far have we come?Eur. Heart J.36 ( 24 ), 1505 – 1511 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Petersen BT , HussainN, MarineJEet al. Technology Assessment Committee. Endoscopy in patients with implanted electronic devices . Gastrointest. Endosc.65 ( 4 ), 561 – 568 ( 2007 ).
   PubMedGoogle Scholar
• St. Jude Medical . Effect of endoscopy on St. Jude medical implantable cardiac rhythm devices . www.sjm.com/∼/media/pro .
   Google Scholar
• Cuschieri JR , OsmanMN, WongRC, ChakA, IsenbergGA . Small bowel capsule endoscopy in patients with cardiac pacemakers and implantable cardioverter defibrillators: outcome analysis using telemetry review . World J. Gastrointest. Endosc.4 ( 3 ), 87 – 93 ( 2012 ).
   PubMedGoogle Scholar
• Stanich PP , KleinmanB, BetkerurK, Mehta OzaN, PorterK, MeyerMM . Video capsule endoscopy is successful and effective in outpatients with implantable cardiac devices . Dig. Endosc.26 ( 6 ), 726 – 730 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Leighton JA , SharmaVK, SrivathsanKet al. Safety of capsule endoscopy in patients with pacemakers . Gastrointest. Endosc.59 ( 4 ), 567 – 569 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Harris LA , HanselSL, RajanEet al. Capsule endoscopy in patients with implantable electromedical devices is safe . Gastroenterol. Res. Pract. 2013, 959234 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Bandorski D , HöltgenR, StunderD, KeuchelM . Capsule endoscopy in patients with cardiac pacemakers, implantable cardioverter defibrillators and left heart assist devices . Ann. Gastroenterol.27 ( 1 ), 3 – 8 ( 2014 ).
   PubMedGoogle Scholar
• Magnani A , BalboP, FacchiniE, OcchettaE, MarinoP . Lack of interference of electromagnetic navigation bronchoscopy to implanted cardioverter-defibrillator: in-vivo study . Europace16 ( 12 ), 1767 – 1771 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Zecchin M , MoreaG, SevergniniMet al. Malfunction of cardiac devices after radiotherapy without direct exposure to ionizing radiation: mechanisms and experimental data . Europace18 ( 2 ), 288 – 293 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Hurkmans CW , KnegjensJL, OeiBSet al. Management of radiation oncology patients with a pacemaker or ICD: a new comprehensive practical guideline in The Netherlands. Dutch Society of Radiotherapy and Oncology (NVRO) . Radiat. Oncol.7, 198 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Borleffs CJ , van ErvenL, van BommelRJet al. Risk of failure of transvenous implantable cardioverter-defibrillator leads . Circ. Arrhythm. Electrophysiol.2 ( 4 ), 411 – 416 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Lambiase PD , BarrC, TheunsDAet al. Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESSS-ICD Registry . Eur. Heart J.35 ( 25 ), 1657 – 1665 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Reddy VY , ExnerDV, CantillonDJet al. Percutaneous implantation of an entirely intracardiac leadless pacemaker . N. Engl. J. Med.373 ( 12 ), 1125 – 1135 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Reynolds D , DurayGZ, OmarRet al. A leadless intracardiac transcatheter pacing system . N. Engl. J. Med.374 ( 6 ), 533 – 541 ( 2016 ).
   PubMed Web of Science ®Google Scholar